464 related items for PubMed ID: 11950009
1. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria.
Gunnarsson I, Sundelin B, Heimbürger M, Forslid J, van Vollenhoven R, Lundberg I, Jacobson SH.
J Rheumatol; 2002 Apr; 29(4):693-9. PubMed ID: 11950009
[Abstract] [Full Text] [Related]
2. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M, Lopez-Trascasa M, Potlukova E, Moll S, Regenass S, Frémeaux-Bacchi V, Martinez-Ara J, Jancova E, Picazo ML, Honsova E, Tesar V, Sadallah S, Schifferli J.
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[Abstract] [Full Text] [Related]
3. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C, Bajema IM, Florquin S, Steenbergen EJ, Peutz-Kootstra CJ, Goldschmeding R, Bijl M, Hagen EC, Van Houwelingen HC, Derksen RH, Berden JH, Dutch Working Party on Systemic Lupus Erythematosus.
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[Abstract] [Full Text] [Related]
4. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
[Abstract] [Full Text] [Related]
5. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
Ann Rheum Dis; 2005 Mar 02; 64(3):444-8. PubMed ID: 15286009
[Abstract] [Full Text] [Related]
6. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
Clin Rheumatol; 2003 Oct 02; 22(4-5):271-8. PubMed ID: 14576989
[Abstract] [Full Text] [Related]
7. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K, Yu Y, Tang Z, Liu Z, Li L.
Chin Med J (Engl); 1997 Jul 02; 110(7):502-7. PubMed ID: 9594205
[Abstract] [Full Text] [Related]
8. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN.
Clin Nephrol; 1996 Sep 02; 46(3):170-5. PubMed ID: 8879851
[Abstract] [Full Text] [Related]
9. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
Faedda R, Palomba D, Satta A, Pirisi M, Tanda F, Bartoli E.
Clin Nephrol; 1995 Dec 02; 44(6):367-75. PubMed ID: 8719548
[Abstract] [Full Text] [Related]
10. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
Arthritis Rheum; 2002 Aug 02; 46(8):2121-31. PubMed ID: 12209517
[Abstract] [Full Text] [Related]
11. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
Gunnarsson I, Sundelin B, Jónsdóttir T, Jacobson SH, Henriksson EW, van Vollenhoven RF.
Arthritis Rheum; 2007 Apr 02; 56(4):1263-72. PubMed ID: 17393458
[Abstract] [Full Text] [Related]
12. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis.
Cai X, Yang X, Lian F, Lin X, Liang M, Li J, Chen X, Liang L, Qin S, Fu J.
J Rheumatol; 2010 Apr 02; 37(4):759-65. PubMed ID: 20194446
[Abstract] [Full Text] [Related]
13. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
Srp Arh Celok Lek; 2002 Aug 02; 130 Suppl 3():19-25. PubMed ID: 12583309
[Abstract] [Full Text] [Related]
14. Simultaneous detection of anti-C1q and anti-double stranded DNA autoantibodies in lupus nephritis: predictive value for renal flares.
Matrat A, Veysseyre-Balter C, Trolliet P, Villar E, Dijoud F, Bienvenu J, Fabien N.
Lupus; 2011 Jan 02; 20(1):28-34. PubMed ID: 20943718
[Abstract] [Full Text] [Related]
15. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA, Radice A, Ikehata M, Giammarresi G, Corace C, Arrigo G, Bollini B, Li Vecchi M.
Ann N Y Acad Sci; 2005 Jun 02; 1050():193-200. PubMed ID: 16014534
[Abstract] [Full Text] [Related]
16. [Laboratory and morphologic parameters in patients with lupus nephritis].
Rasković S, Bogić M, Perić-Popadić A, Stefanović L, Arandjelović S, Jovicić Z, Bolpacić J, Tomić-Spirić V.
Srp Arh Celok Lek; 2002 Aug 02; 130 Suppl 3():38-41. PubMed ID: 12583312
[Abstract] [Full Text] [Related]
17. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC, Zhou B, Dong Y.
Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001
[Abstract] [Full Text] [Related]
18. Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures.
Wakasugi D, Gono T, Kawaguchi Y, Hara M, Koseki Y, Katsumata Y, Hanaoka M, Yamanaka H.
J Rheumatol; 2012 Jan 13; 39(1):79-85. PubMed ID: 22089455
[Abstract] [Full Text] [Related]
19. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
Arthritis Rheum; 2004 Aug 13; 50(8):2559-68. PubMed ID: 15334470
[Abstract] [Full Text] [Related]
20. [Lupus nephritis in children and adolescents: therapy, clinical course and prognosis].
Bogdanović R, Nikolić V, Ognjanović M, Dimitrijević J, Marković-Lipkovski J, Pasić S, Minić A, Stajić N.
Srp Arh Celok Lek; 2002 Aug 13; 130 Suppl 3():6-12. PubMed ID: 12583307
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
